Why Bristol-Myers Squibb Ending A Drug Trial Early Is A Good Thing By: Benzinga via Benzinga April 17, 2015 at 13:47 PM EDT Adam Feuerstein was recently a guest on #PreMarket Prep, a daily trading idea radio show hosted by Joel Elconin and Dennis ... Read More >> Related Stocks: Bristol-Myers Squibb